Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies-Reference-Cited by-同舟云学术

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

Published:2003-06 Issue:21-22 Volume:21 Page:2954-2963
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Yasuda Yoko,Isaka Masanori,Taniguchi Tooru,Zhao Yanqiu,Matano Keiko,Matsui Hideyuki,Morokuma Kazunori,Maeyama Jun-ichi,Ohkuma Kunio,Goto Norihisa,Tochikubo Kunio

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen;Elson;J. Immunol.,1984

2. Elson CO. Cholera toxin as a mucosal adjuvant. In: Kiyono H, Ogra PL, McGhee JR, editors. Mucosal vaccines. Sun Diego: Academic Press; 1996. p. 59–72.

3. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis;Ichikawa;FEMS Microbiol. Lett.,1993

4. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant;Yasuda;FEMS Immunol. Med. Microbiol.,1998

5. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant;Goto;Vaccine,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines: present status and applications;Animal Biotechnology;2020

2. Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model;BMC Research Notes;2016-02-09

3. Vaccines;Animal Biotechnology;2014

4. Alternative vaccine delivery methods;Vaccines;2013

5. Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity;Vaccine;2010-05